Nucleozin
CAY-30363-50 50 mg
Data Sheet: 
SDS:
SDS:
CAS
341001-38-5
Formulation
A crystalline solid
Purity
≥98%
MW
426,85282
Shipment
-20
Long Term Storage
-20
Shelf Life
1460
Description
An antiviral; prevents influenza nucleoprotein from accumulating in the nucleus; inhibits MDCK cell infection by influenza A and H5N1 (EC50s = 0.069 and 0.33 µM, respectively), as well as a clinical isolate of H3N2 (EC50 = 0.16 µM); reduces the lung viral load and increases the survival rate in a mouse model of influenza H5N1 infection
ESCLUSIVAMENTE PER USO DI RICERCA (RUO) e non per uso terapeutico o diagnostico su uomini o animali. Il prodotto NON è un Dispositivo Medico o un Diagnostico in Vitro.
PRODUCT FOR RESEARCH USE ONLY (RUO) and not for therapeutic or diagnostic use on humans or animals. The product is NOT a Medical Device or an In-Vitro Diagnostic (IVD).
